Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_assertion type Assertion NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_head.
- NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_assertion description "[Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_provenance.
- NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_assertion evidence source_evidence_literature NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_provenance.
- NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_assertion SIO_000772 26433819 NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_provenance.
- NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_assertion wasDerivedFrom befree-2016 NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_provenance.
- NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_assertion wasGeneratedBy ECO_0000203 NP1294669.RAVLY8oWbLBiI27nrj0joPAvPqKvS_oPVfwelByCTwQAw130_provenance.